首页> 外文OA文献 >Non-small cell lung cancer in the elderly: A retrospective study comparing first-line treatment with single-agent vs combination chemotherapy vs tyrosine kinase inhibitor

【2h】

Non-small cell lung cancer in the elderly: A retrospective study comparing first-line treatment with single-agent vs combination chemotherapy vs tyrosine kinase inhibitor

机译：老年人的非小细胞肺癌：一种回顾性研究，比较单患者与单孕联合化疗的一线治疗与酪氨酸激酶抑制剂

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
É. Cipriano; A. Tavares; A. Soares; F. Estevinho; C. Sottomayor;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy of first-line treatment with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) alone or in combination with chemotherapy for advanced non-small cell lung cancer (NSCLC) with low-abundance mutation [J] . Yan Xiangtao, Wang Huijuan, Li Peng, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2019,第期

机译：单独或与低丰度突变的先进非小细胞肺癌（NSCLC）组合单独使用表皮生长因子受体 - 酪氨酸激酶抑制剂（EGFR-TKI）的疗效。
2. The ELVIS trial: a phase III study of single-agent vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer. Elderly Lung Cancer Vinorelbine Italian Study. [J] . Gridelli C The oncologist . 2001,第Suppla1期

机译：ELVIS试验：长春瑞滨单药单药治疗老年晚期非小细胞肺癌的一线治疗。老年肺癌Vinorelbine意大利研究。
3. Single-agent versus combination chemotherapy as first-line treatment for patients with advanced non-small cell lung cancer and performance status 2: A literature-based meta-analysis of randomized studies [J] . M?rthC., ValachisA. Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2014,第3期

机译：单药与联合化疗作为晚期非小细胞肺癌和表现状态患者的一线治疗方法：基于文献的随机研究的荟萃分析
4. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
5. Unanticipated Effects of Tyrosine Kinase Inhibitors on Vitamin D Receptor Expression and Gene Regulation In Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer. [D] . Timberlake, Alexandra F. 2017

机译：酪氨酸激酶抑制剂对表皮生长因子受体突变的非小细胞肺癌中维生素D受体表达和基因调控的意外影响。
6. A multicenter randomized controlled open-label trial to assess the efficacy of compound kushen injection in combination with single-agent chemotherapy in treatment of elderly patients with advanced non-small cell lung cancer: study protocol for a randomized controlled trial [O] . Xue-qian Wang, Jie Liu, Hong-sheng Lin, 2016

机译：多中心随机对照开放标签试验评估复方苦参注射液与单药化疗联合治疗老年晚期非小细胞肺癌的疗效：一项随机对照试验的研究方案
7. >Association Of Initial Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment And EGFR Exon 19 Deletion With Frequency Of The T790M Mutation In Non-Small Cell Lung Cancer Patients After Resistance To First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors [O] . Wen Gao, Jing He, Shi-Dai Jin, 2019

机译：>初始表皮生长因子受体酪氨酸激酶抑制剂治疗和EGFR外显子抑制剂的抗血液抗性抗血液肺癌患者T790M突变抗性抗性后，抗抗血疱剂患者的抗性，抗抗血管生长因子受体酪氨酸激酶抑制剂

Non-small cell lung cancer in the elderly: A retrospective study comparing first-line treatment with single-agent vs combination chemotherapy vs tyrosine kinase inhibitor

著录项

引文网络

相似文献

相关主题

期刊订阅